Correction: Dual blockade with AFatinib and trastuzumab as NEoadjuvant treatment for patients with locally advanced or operable breast cancer receiving taxane-anthracycline containing chemotherapy-DAFNE (GBG-70)

In this article ([Clin Cancer Res 2015;21:2924-31][1]), which was published in the July 1, 2015, issue of Clinical Cancer Research ([1][2]), an incorrect clinicaltrials.gov trial registration number (NCT015591477) was printed in the abstract. The correct trial registration number is [NCT01594177][

Bibliographic Details

Main Authors:	Hanusch, Claus Alexander (Author) , Schneeweiss, Andreas (Author) , Loibl, Sibylle (Author) , Untch, Michael (Author) , Paepke, Stefan (Author) , Kümmel, Sherko (Author) , Jackisch, Christian (Author) , Huober, Jens (Author) , Hilfrich, Jörn (Author) , Gerber, Bernd (Author) , Eidtmann, Holger (Author) , Denkert, Carsten (Author) , Costa, Serban (Author) , Blohmer, Jens Uwe (Author) , Engels, Knut (Author) , Burchardi, Nicole (Author) , Minckwitz, Gunter von (Author)
Format:	Article (Journal)
Language:	English
Published:	September 1, 2016
In:	Clinical cancer research Year: 2016, Volume: 22, Issue: 17, Pages: 4536-4536
ISSN:	1557-3265
DOI:	10.1158/1078-0432.CCR-16-1594
Online Access:	Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1158/1078-0432.CCR-16-1594 Verlag, lizenzpflichtig, Volltext: https://clincancerres.aacrjournals.org/content/22/17/4536
Author Notes:	Claus Hanusch, Andreas Schneeweiss, Sibylle Loibl, Michael Untch, Stefan Paepke, Sherko Kümmel, Christian Jackisch, Jens Huober, Jörn Hilfrich, Bernd Gerber, Holger Eidtmann, Carsten Denkert, Serban Costa, Jens Uwe Blohmer, Knut Engels, Nicole Burchardi, and Gunter von Minckwitz